We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

134 hedge funds and large institutions have $238M invested in Viking Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 47 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

476% more call options, than puts

Call options by funds: $8.98M | Put options by funds: $1.56M

5% more capital invested

Capital invested by funds: $227M → $238M (+$11M)

0.19% less ownership

Funds ownership: 48.49% → 48.3% (-0.19%)

3% less funds holding

Funds holding: 138 → 134 (-4)

15% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 47

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

Holders
134
Holders Change
-4
Holders Change %
-2.9%
% of All Funds
2.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
40
Reduced
47
Closed
12
Calls
$8.98M
Puts
$1.56M
Net Calls
+$7.42M
Net Calls Change
+$1.98M

Top Buyers

1
N
Nuveen
North Carolina
+$5.13M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.66M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$1.99M
4
UBS Group
UBS Group
Switzerland
+$635K
5
First Trust Advisors
First Trust Advisors
Illinois
+$611K

Top Sellers

1
State Street
State Street
Massachusetts
-$5.83M
2
Citigroup
Citigroup
New York
-$1.21M
3
Morgan Stanley
Morgan Stanley
New York
-$1.18M
4
Goldman Sachs
Goldman Sachs
New York
-$935K
5
ACM
ACT Capital Management
Pennsylvania
-$770K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACH
1
ArrowMark Colorado Holdings
Colorado
$50.2M +$1.99M +322,659 +4%
BlackRock
2
BlackRock
New York
$32.2M -$735K -118,917 -2%
State Street
3
State Street
Massachusetts
$25.4M -$5.83M -943,709 -19%
Vanguard Group
4
Vanguard Group
Pennsylvania
$21.1M +$520K +84,142 +3%
PWAM
5
Park West Asset Management
California
$10.5M – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$7.46M +$167K +26,997 +2%
N
7
Nuveen
North Carolina
$7.45M +$5.13M +829,824 +293%
Fiera Capital (Canada)
8
Fiera Capital (Canada)
Quebec, Canada
$6.71M -$101K -16,386 -2%
Northern Trust
9
Northern Trust
Illinois
$6.11M -$162K -26,294 -3%
Two Sigma Advisers
10
Two Sigma Advisers
New York
$5.9M -$280K -45,400 -5%
Two Sigma Investments
11
Two Sigma Investments
New York
$5.5M +$299K +48,380 +6%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$4.82M +$2.66M +430,845 +128%
SCM
13
Sio Capital Management
New York
$4.15M +$253K +41,033 +7%
IC
14
Ikarian Capital
Texas
$3.14M -$149K -24,112 -5%
DCM
15
DAFNA Capital Management
California
$2.81M – – –
Macquarie Group
16
Macquarie Group
Australia
$2.08M – – –
PPA
17
Parametric Portfolio Associates
Washington
$1.95M +$34.8K +5,634 +2%
Bank of America
18
Bank of America
North Carolina
$1.84M +$91.7K +14,839 +5%
New York State Common Retirement Fund
19
New York State Common Retirement Fund
New York
$1.8M -$92.5K -14,969 -5%
Deutsche Bank
20
Deutsche Bank
Germany
$1.76M -$16.6K -2,685 -0.9%
UBS Group
21
UBS Group
Switzerland
$1.7M +$635K +102,785 +61%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$1.67M +$100K +16,191 +6%
Morgan Stanley
23
Morgan Stanley
New York
$1.62M -$1.18M -190,852 -43%
RJA
24
Raymond James & Associates
Florida
$1.58M -$49.9K -8,085 -3%
DMK
25
David M. Knott
$1.31M – – –
1
2 3 4 5

VKTX Hedge Fund Activity: Q3 2021 in Review

134 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q3 2021, worth a combined $238M — up 4.9% from $227M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of VKTX and 9 opened new positions — a net loss of 3 holders — while 47 trimmed existing stakes and 40 added.

The largest buyer was Nuveen, adding an estimated $5.13M. The largest seller was State Street, cutting an estimated $5.83M.

  • 134 institutional investors held Viking Therapeutics (VKTX) as of Q3 2021, down from 138 in Q2 2021.
  • Funds reported $238M of Viking Therapeutics stock for Q3 2021, up 4.9% quarter-over-quarter.
  • 9 funds opened new Viking Therapeutics positions in Q3 2021 and 12 closed out, a net change of -3 holders.
  • The largest Viking Therapeutics buyer in Q3 2021 was Nuveen, an estimated $5.13M added.
  • The largest Viking Therapeutics seller in Q3 2021 was State Street, an estimated $5.83M sold.

Based on aggregated 13F filings for Q3 2021.